Here we present a blood-brain barrier (BBB) model that enables high-resolution imaging of nanoparticle (NP) interactions with endothelial cells and the capture of rare NP translocation events. The enabling technology is an ultrathin silicon nitride (SiN) membrane (0.5 μm pore size, 20% porosity, 400 nm thickness) integrated into a dual-chamber platform that facilitates imaging at low working distances (∼50 μm). The platform, the μSiM-BBB (microfluidic silicon membrane-BBB), features human brain endothelial cells and primary astrocytes grown on opposite sides of the membrane. The human brain endothelial cells form tight junctions on the ultrathin membranes and exhibit a significantly higher resistance to FITC-dextran diffusion than commercia...
<div><p>The blood-brain barrier prevents the entry of many therapeutic agents into the brain. Variou...
A preclinical blood-brain barrier (BBB) model is important for the study of fundamental transport me...
We describe here the design and implementation of an in vitro microvascular open model system using ...
Here we present a blood-brain barrier (BBB) model that enables high-resolution imaging of nanopartic...
Here we report on the development of a breakthrough microfluidic human in vitro cerebrovascular...
Here we report on the development of a breakthrough microfluidic human in vitro cerebrovascular barr...
Nanoparticles (NPs) are being used or explored for the development of biomedical applications in dia...
Understanding nanoparticle interactions with the central nervous system, in particular the blood-bra...
\u3cp\u3eThe delivery of therapeutics to the brain is greatly hampered by the blood-brain barrier (B...
More and more people in the world suffer from various brain diseases such as Parkinson’s disease, Al...
The possibility of nanoparticle (NP) uptake to the human central nervous system is a major concern. ...
Understanding nanoparticle interactions with the central nervous system, in particular the blood–bra...
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Polymer nanoparticles (NPs), due to their small ...
A realistic model of the blood-brain barrier (BBB) is valuable to perform drug screening experiments...
Challenges in drug development of neurological diseases remain mainly ascribed to the blood-brain ba...
<div><p>The blood-brain barrier prevents the entry of many therapeutic agents into the brain. Variou...
A preclinical blood-brain barrier (BBB) model is important for the study of fundamental transport me...
We describe here the design and implementation of an in vitro microvascular open model system using ...
Here we present a blood-brain barrier (BBB) model that enables high-resolution imaging of nanopartic...
Here we report on the development of a breakthrough microfluidic human in vitro cerebrovascular...
Here we report on the development of a breakthrough microfluidic human in vitro cerebrovascular barr...
Nanoparticles (NPs) are being used or explored for the development of biomedical applications in dia...
Understanding nanoparticle interactions with the central nervous system, in particular the blood-bra...
\u3cp\u3eThe delivery of therapeutics to the brain is greatly hampered by the blood-brain barrier (B...
More and more people in the world suffer from various brain diseases such as Parkinson’s disease, Al...
The possibility of nanoparticle (NP) uptake to the human central nervous system is a major concern. ...
Understanding nanoparticle interactions with the central nervous system, in particular the blood–bra...
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Polymer nanoparticles (NPs), due to their small ...
A realistic model of the blood-brain barrier (BBB) is valuable to perform drug screening experiments...
Challenges in drug development of neurological diseases remain mainly ascribed to the blood-brain ba...
<div><p>The blood-brain barrier prevents the entry of many therapeutic agents into the brain. Variou...
A preclinical blood-brain barrier (BBB) model is important for the study of fundamental transport me...
We describe here the design and implementation of an in vitro microvascular open model system using ...